SRL
REPL icon

Scientech Research LLC’s Replimune Group REPL Stock Holding History

Scientech Research LLC’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,720
Closed -$82K – 484
2026
Q1 		$82K Buy
+10,720
New +$81.9K 0.07% 363
2025
Q4 		– Sell
-24,434
Closed -$102K – 751
2025
Q3 		$102K Buy
+24,434
New +$156K 0.04% 497

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Scientech Research LLC's REPL Position: Q2 2026 in Review

Scientech Research LLC sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 10,720 shares — an estimated $82K sold.

Scientech Research LLC first reported a position in REPL in Q3 2025 and held it in 2 quarters. The position peaked at $102K in Q3 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Scientech Research LLC reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 10,720 Replimune Group shares in Q2 2026, an estimated $82K.
  • Scientech Research LLC first reported a position in Replimune Group in Q3 2025 and held it in 2 quarters.
  • Scientech Research LLC's Replimune Group position peaked at $102K in Q3 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.